Form 4 for IGC IGC Pharma, Inc.
Accepted 2025-10-21 00:00:00 ET · period of report 2025-10-17 · accession 0001185185-25-001504 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-10-21 | 2025-10-17 | IGC | GRIMALDI CLAUDIA | PFO, Dir | G - Gift | $0.00 | -50.0K | 1.13M | -4% | $0 |
| DM | 2025-10-21 | 2025-10-17 | IGC | GRIMALDI CLAUDIA | PFO, Dir | A - Grant | $0.00 | +1.50M | 1.00M | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-17 | G | D | 50,000 | $0.00 | 1,134,252 | D | — | — | (F3) Gift of shares of the Company's common stock to the reporting person's children who do not share the reporting person's household. |
| 2 | Derivative | Options | 2025-10-17 | A | A | 500,000 | $0.00 | 500,000 | D | — · — to 2036-03-31 | 500,000 Common Stock | (F2) The Reporting Person was granted Options subject to vesting according to specific milestones set by the Company's Board of Directors. The Options vest upon achievement of milestones. The exercise price is $0.35. |
| 3 | Derivative | Options | 2025-10-17 | A | A | 1,000,000 | $0.00 | 1,000,000 | D | — · — to 2038-03-31 | 1,000,000 Common Stock | (F1) The Reporting Person was granted 1,000,000 options exercisable at $0.35, equally vesting over the next three years starting March 31st, 2026. |